Standardized method for quantification of developing lymphedema in patients treated for breast cancer. - Wikidata - wikimedia - TriplyDB

Standardized method for quantification of developing lymphedema in patients treated for breast cancer.

Standardized method for quantification of developing lymphedema in patients treated for breast cancer.

http://www.wikidata.org/entity/Q34186773

about

Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned.Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.Manual lymphatic drainage for breast cancer-related lymphoedema.Efficacy of night-time compression for breast cancer related lymphedema (LYNC): protocol for a multi-centre, randomized controlled efficacy trial.Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer.Lymphedema following treatment for breast cancer: a new approach to an old problem.Cording following treatment for breast cancer.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.Role of handedness on forearm skin tissue dielectric constant (TDC) in relation to detection of early-stage breast cancer-related lymphedema.A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA.Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model.Standardized approach to lymphedema screening.Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living.Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer.Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review.The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema.Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema.Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments

P2860

Q33571995-9A1B4173-8F38-49CC-8765-F21CE66132A4 Q35607357-E3FFDEB1-B409-4A3D-B45D-FD6C48B1E413 Q35824452-A92D0BBF-8203-4EF1-9942-3F47820707A7 Q35868204-3746FD8A-3B15-4DF0-9028-527CE7491CAD Q36014315-05A163CF-4852-450E-B916-732DD66A5E4E Q36095233-9166CAAB-438A-4064-B109-9CF057CA6022 Q36223878-FC78D938-647D-47A2-BB3E-77B1BE3DD420 Q36584805-7ED6E7C9-C1F2-44B8-B573-AA7D67C892BA Q36587170-9F95E513-2E30-4FB3-91DA-462C5D296C1C Q36914435-FCD8D1B1-2A40-4173-9E46-CB88746C792D Q37200954-3662710B-32B6-4D97-833A-BF49EB9F0CD1 Q37205522-CE857000-7E3C-43FE-B7DB-F38C70DDBBAA Q37210955-12F39C05-5EEF-402B-892B-6AA8C5F345E0 Q37416098-F7A33BF1-1F3F-4DA9-9B48-1F4EBC394DBF Q37592836-6E3C9312-E207-4698-AC17-A7F5DB87FA92 Q38631021-FB630727-5DD8-4409-818F-68EC286BD57D Q38890612-72E786D2-F510-4116-A313-181202153FBC Q39052241-978498EF-4108-4E6B-B15D-F10E7CCAC70B Q40872781-1D2E398C-1B0E-4FAD-90A2-7BB9D69D2B05 Q40961186-30471D6F-CA27-4F65-8569-3ED7C225C7D6 Q42129574-4157507B-EE20-4AFE-A8C2-1AB76C28494E Q42910793-6DC4A239-5DA2-45A8-9F6C-B247AE7C89D2 Q45179350-8FEBE32D-3649-4125-9DA6-A1143AEDF6EF Q45969600-47446030-7D2D-4B8C-87D7-66B9B554E154 Q47569260-E1523A92-314A-42B6-9D4B-C7B4BB51ACDE Q48046748-29CFF3BF-5AA2-43B3-8803-479EED898657 Q48321725-CDA529CE-2B20-4922-BDA7-2C9FFE1C6BF6 Q48506576-9DDD8CAC-B850-4D77-AAF7-63CE5D9F404F Q50855417-76F2C38D-0AE0-4782-9F3D-B16445473892 Q54377198-2D8FD8EA-D84E-4676-A289-CC99BBE9ABA8 Q57108719-649269AF-9167-44C2-8FB3-48F76DA762AF

P2860

Standardized method for quantification of developing lymphedema in patients treated for breast cancer.

http://www.wikidata.org/entity/Q34186773

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Standardized method for quanti ...... nts treated for breast cancer.

@ast

Standardized method for quanti ...... nts treated for breast cancer.

@en

Standardized method for quanti ...... nts treated for breast cancer.

@nl

type

label

Standardized method for quanti ...... nts treated for breast cancer.

@ast

Standardized method for quanti ...... nts treated for breast cancer.

@en

Standardized method for quanti ...... nts treated for breast cancer.

@nl

prefLabel

Standardized method for quanti ...... nts treated for breast cancer.

@ast

Standardized method for quanti ...... nts treated for breast cancer.

@en

Standardized method for quanti ...... nts treated for breast cancer.

@nl

P1433

Q34186773-5E44F0B5-CF7B-4C6F-A7D3-FCFFFEC6B0E6

P1476

Q34186773-637276BA-7C84-4B5F-8A81-84C3454AB158

P2093

Q34186773-11C65465-1DBE-42AE-97D2-6564A04B3B7A

Q34186773-25B2C432-54DA-437F-89FD-9A73F1A1EF83

Q34186773-314E58BF-6411-4695-86CE-86296E6A89C7

Q34186773-47189628-4ED2-477D-9A98-00E57D61EC9D

Q34186773-49C74D5E-AD62-428B-BF1E-DF077367887A

Q34186773-4D61F0A3-AC41-4A36-9F7A-E7CA66D00404

Q34186773-8A208B0E-939A-4C65-B583-161F095A72DB

Q34186773-A0103FE9-31C6-4359-8861-918F4FBE4614

Q34186773-A97419F0-B9D3-41C5-9726-0CEA587035E8

Q34186773-C75DC219-B217-4B89-85F0-9DCAED0A5D57

P2860

Q34186773-159DC92D-CD42-41DF-8BED-D8120755AF46

Q34186773-3DEE5C3A-5219-462F-A36F-45BE02BC8BEE

Q34186773-6F7E667E-EFCF-4C8C-A2CA-45B93942852F

Q34186773-A394CD73-8B20-4F4E-B6FD-89E76213B4C7

Q34186773-B245B211-D03D-4DCF-847B-DFC289C80585

Q34186773-B5D417B2-41CD-4CCE-A327-33D271E0BD98

Q34186773-B8C3DE75-1041-4F14-8069-589C4E79AF07

Q34186773-C4258F12-89C4-4548-BB47-E7BE28E1018A

Q34186773-C6F415FA-D756-4862-B5C3-E5C55F22C5AB

Q34186773-D57D3AFD-0B9B-4E34-995F-12B79A554EA5

P304

Q34186773-FE0E0B07-7798-42DB-A660-92FC694FB03C

P31

Q34186773-5074F164-3978-4925-972D-10A8455BDE48

P356

Q34186773-27F7A36F-9A6E-445A-AEE0-E820B92CC950

P407

Q34186773-1A90BE8A-B29A-402C-A256-9B128BE217A9

P433

Q34186773-D7790E93-229C-4705-9A31-503452E1AA49

P478

Q34186773-4488AFFC-8A33-49A2-A653-0946D11232BE

P577

Q34186773-2F17F708-3EB8-4ABF-A189-C331743A8079

P5875

Q34186773-3F8F5F97-6561-4F40-9698-761949B276F5

P698

Q34186773-3D03D046-66DA-4A54-B34F-DDEF3492F5F1

P932

Q34186773-25304E16-7A4A-4188-B910-9A763B8B2C73

P356

J.IJROBP.2010.01.001

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Standardized method for quanti ...... nts treated for breast cancer.

@en

P2093

Alexandra Kelada

http://www.w3.org/2001/XMLSchema#string

Alphonse G Taghian

http://www.w3.org/2001/XMLSchema#string

Barbara L Smith

http://www.w3.org/2001/XMLSchema#string

Colleen D Murphy

http://www.w3.org/2001/XMLSchema#string

Jean Otoole

http://www.w3.org/2001/XMLSchema#string

Jessica Pogachar

http://www.w3.org/2001/XMLSchema#string

Marek Ancukiewicz

http://www.w3.org/2001/XMLSchema#string

Marybeth Singer

http://www.w3.org/2001/XMLSchema#string

Megha Patel

http://www.w3.org/2001/XMLSchema#string

Melissa Skolny

http://www.w3.org/2001/XMLSchema#string

P2860

A review of measures of lymphedema.

Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteers and individuals with known lymphedema.

The psycho-social impact of lymphedema.

Arm edema in breast cancer patients.

The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology.

A clinically useful method for evaluating lymphedema.

The epidemiology of arm and hand swelling in premenopausal breast cancer survivors

Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study.

Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.

The problem of post-breast cancer lymphedema: impact and measurement issues.

P304

1436-1443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2010.01.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45096332

http://www.w3.org/2001/XMLSchema#string

P698

20605339

http://www.w3.org/2001/XMLSchema#string

P932

2952286

http://www.w3.org/2001/XMLSchema#string